PANTHER

Serial Number 99434165
630

Registration Progress

Application Filed
Oct 9, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

PANTHER

Basic Information

Serial Number
99434165
Filing Date
October 9, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
630
Status Date
Oct 9, 2025
Application
Pending
Classes
005 010

Rights Holder

PanTher Therapeutics, Inc.

03
Address
7000 BEE CAVES ROAD, SUITE 300
AUSTIN, TX 78746

Ownership History

PanTher Therapeutics, Inc.

Original Applicant
03
AUSTIN, TX

Legal Representation

Attorney
Andrew D. Skale

Application History

3 events
Date Code Type Description Documents
Oct 9, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 9, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 9, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products in the nature of implantable solid drug formulations for the treatment of cancer; Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of pharmaceuticals for the prevention, diagnosis, and treatment of cancer; Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate localized delivery of pharmaceuticals for the sustained treatment of cancer; Pharmaceutical products in the nature of implantable solid drug formulations that improve therapeutic efficacy, minimize systemic toxicity, and expand treatment options, all related to cancer
First Use Anywhere: Jun 19, 2017
First Use in Commerce: Jun 19, 2017
Class 010
Implantable solid drug formulations to treat cancer; Drug delivery system in the nature of a system that delivers an implantable solid drug formulation to treat cancer; Drug delivery system in the nature of a system to prevent, diagnose, and treat cancer; Drug delivery system that facilitates delivery of pharmaceuticals that improve therapeutic efficacy, minimize systemic toxicity, and expand treatment options, all related to cancer
First Use Anywhere: Jun 19, 2017
First Use in Commerce: Jun 19, 2017

Classification

International Classes
005 010